Bruce Goldsmith
Operating Partner at ALSA Ventures
About
A pharma and biotech leader with 25 years of experience, Bruce held senior roles at Johnson & Johnson, Allos Therapeutics and Lycera, was a Venture Partner at Deerfield, and served as CEO of Passage Bio through its IPO. He holds a PhD in Biology and an MBA.
Colleagues at ALSA Ventures
Alek Safarian
CEO at ALSA Ventures
Andre Badalyan
Senior Analyst at ALSA Ventures
Gerard Evan
Advisor at ALSA Ventures
Graeme Martin
Venture Partner at ALSA Ventures
Jasmin Fisher
Advisor at ALSA Ventures
Julia Jones
Investment Manager at ALSA Ventures
Jyoti Choudhary
Advisor at ALSA Ventures
Katie Sunnucks
Associate at ALSA Ventures